Generative biology is moving from code to the clinic, promising faster drug discovery while raising hard questions about safety, proof and control.

Generative biology is moving from code to the clinic, promising faster drug discovery while raising hard questions about safety, proof and control.

Insilico Medicine has shown that generative AI can dramatically accelerate drug discovery, but its bigger challenge is turning one breakthrough into a repeatable process.